About: Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.46 (-0.68%)
ENVB NASDAQ Enveric Biosciences Inc
Enveric Biosciences Inc share price
Atividade de preço de ENVB
Último preço
$ 1,460
Variação (24h)
-0,01 USD (0,68%)
Volume
27.92K
Volume (média 4 sem.)
-
Abertura
$ 1,43
Variação do dia
$ 1,42 - $ 1,49
Fechamento anterior
$ 1,47
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ENVB price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals